220 related articles for article (PubMed ID: 23915292)
1. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.
Andersson ML; Svensson B; Petersson IF; Hafström I; Albertsson K; Forslind K; Heinegård D; Saxne T
BMC Musculoskelet Disord; 2013 Aug; 14():229. PubMed ID: 23915292
[TBL] [Abstract][Full Text] [Related]
2. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.
Roux-Lombard P; Eberhardt K; Saxne T; Dayer JM; Wollheim FA
Rheumatology (Oxford); 2001 May; 40(5):544-51. PubMed ID: 11371663
[TBL] [Abstract][Full Text] [Related]
3. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
[TBL] [Abstract][Full Text] [Related]
4. Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study.
de Jong Z; Munneke M; Vilim V; Zwinderman AH; Kroon HM; Ronday HK; Lems WF; Dijkmans BA; Breedveld FC; Vliet Vlieland TP; Hazes JM; Degroot J
Rheumatology (Oxford); 2008 Jun; 47(6):868-71. PubMed ID: 18400837
[TBL] [Abstract][Full Text] [Related]
5. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
Syversen SW; Goll GL; van der Heijde D; Landewé R; Gaarder PI; Odegård S; Haavardsholm EA; Kvien TK
J Rheumatol; 2009 Feb; 36(2):266-72. PubMed ID: 19132792
[TBL] [Abstract][Full Text] [Related]
6. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
Lindqvist E; Eberhardt K; Bendtzen K; Heinegård D; Saxne T
Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
[TBL] [Abstract][Full Text] [Related]
7. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
Wisłowska M; Jabłońska B
Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
[TBL] [Abstract][Full Text] [Related]
8. Cartilage Oligomeric Matrix Protein (COMP) in systemic sclerosis (SSc): role in disease severity and subclinical rheumatoid arthritis overlap.
Gheita TA; Hussein H
Joint Bone Spine; 2012 Jan; 79(1):51-6. PubMed ID: 21497537
[TBL] [Abstract][Full Text] [Related]
9. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
10. Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab.
Kawashiri SY; Kawakami A; Ueki Y; Imazato T; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Origuchi T; Ida H; Eguchi K
Joint Bone Spine; 2010 Oct; 77(5):418-20. PubMed ID: 20864374
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
Skoumal M; Kolarz G; Klingler A
Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.
Niki Y; Takeuchi T; Nakayama M; Nagasawa H; Kurasawa T; Yamada H; Toyama Y; Miyamoto T
PLoS One; 2012; 7(5):e37447. PubMed ID: 22629396
[TBL] [Abstract][Full Text] [Related]
13. Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Filippucci E; Grassi W
BMC Musculoskelet Disord; 2011 May; 12():120. PubMed ID: 21624120
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.
Young-Min S; Cawston T; Marshall N; Coady D; Christgau S; Saxne T; Robins S; Griffiths I
Arthritis Rheum; 2007 Oct; 56(10):3236-47. PubMed ID: 17907159
[TBL] [Abstract][Full Text] [Related]
15. [Functional capacity and cartilage oligomeric protein (COMP) in serum of patients with maturity-onset polyarthritis].
Kolarz G; Hermann J; Krajnc I; Palkonyai E; Scherak O; Schödl Ch; Singer F; Temesvari P; Wagner E; Wottawa A
Z Rheumatol; 2002 Aug; 61(4):435-9. PubMed ID: 12426849
[TBL] [Abstract][Full Text] [Related]
16. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.
Nyhäll-Wåhlin BM; Turesson C; Jacobsson LT; Nilsson JÅ; Forslind K; Albertsson K; Rönnelid J; Petersson IF
Scand J Rheumatol; 2011 Mar; 40(2):81-7. PubMed ID: 20919947
[TBL] [Abstract][Full Text] [Related]
17. Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet.
Fex E; Eberhardt K; Saxne T
Br J Rheumatol; 1997 Nov; 36(11):1161-5. PubMed ID: 9402859
[TBL] [Abstract][Full Text] [Related]
18. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM
J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710
[TBL] [Abstract][Full Text] [Related]
19. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
Aletaha D; Smolen JS
Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
[TBL] [Abstract][Full Text] [Related]
20. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment.
Happonen KE; Saxne T; Geborek P; Andersson M; Bengtsson AA; Hesselstrand R; Heinegård D; Blom AM
Arthritis Res Ther; 2012 Jan; 14(1):R15. PubMed ID: 22264230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
